BHK Investment Advisors’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
AC
BHK Investment Advisors's KYNB Position: Q4 2023 in Review
BHK Investment Advisors sold out of Kyntra Bio (KYNB) in Q4 2023, closing a stake of 2,305 shares — an estimated $49.7K sold.
BHK Investment Advisors first reported a position in KYNB in Q4 2017 and held it in 24 quarters. The position peaked at $1.59M in Q1 2023. 100 funds tracked by Wall St. Rank hold KYNB as of Q4 2023.
- BHK Investment Advisors reported no remaining Kyntra Bio position as of Q4 2023 after selling out during the quarter.
- BHK Investment Advisors sold 2,305 Kyntra Bio shares in Q4 2023, an estimated $49.7K.
- BHK Investment Advisors first reported a position in Kyntra Bio in Q4 2017 and held it in 24 quarters.
- BHK Investment Advisors's Kyntra Bio position peaked at $1.59M in Q1 2023.
- 100 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2023.
Based on BHK Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.